Antibiotic resistance in gonorrhea bacterial cell being inhibited. There is a possibility of future enzymes (made by the bacterium) that will be able to denature and inactivate the aminoglycosides. Antibiotic resistance in gonorrhea The Gonorrhea bacterium Neisseria gonorrhoeae has developed antibiotic resistance to many antibiotics. The bacteria was first identified in 1879, although some Biblical scholars believe that references to the disease can be found as early as Parshat Metzora of the Old Testament. In the 1940s effective treatment with penicillin became available, but by the 1970s resistant strains predominated. Resistance to penicillin has developed through two mechanisms: chromasomally mediated resistance (CMRNG) and penicillinase-mediated
Antibiotic resistance in gonorrhea the "parC" gene which encodes for the topoisomerase IV. Topoisomerase IV acts similarly to DNA gyrase and is involved in unwinding DNA for replication. Ceftriaxone and cefixime are third generation cephalosporins and are often used as treatments for "N. gonorrhoeae infections". The cephalosporins are part of a larger beta-lactam family of antibiotics. The newly discovered H041 strain of "N. gonorrhoeae", originally isolated from a commercial sex worker in Japan, was shown to be resistant to this antibiotic. The possible mechanisms of resistance to this antibiotic are as follows: Tetracyclines are a class of antibiotics that inhibit protein synthesis by binding